Organogenesis Holdings ORGO stock decreased by 43.36% to $3.02. The market value of their outstanding shares is at $383.7 million. As per the press release, Q1 earnings came out yesterday.

The theme for today’s purple category is URL ENDINGS PLUS A LETTER and the words are: COMP, MILK, NETI, ORGO. NETI could refer to a NETI pot, which is used to flush out the nasal cavity.

This reflects the efforts of the World Taekwondo Federation (WTF) and the Taekwondo Humanitarian Foundation (THF) to strengthen humanitarian activities in collaboration with various international ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Accordingly, I rate Organogenesis as a "Hold". Analyst’s Disclosure: I/we have a beneficial long position in the shares of ORGO either through stock ownership, options, or other derivatives.

$ORGO insiders have traded $ORGO stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales. Here’s a ...

These bimetallic bases are clearly rather special, and writing in Nature Chemistry, the same group of chemists report another such reagent with the ability to persuade THF to act out of character 5.

2025 Adjusted EBITDA Guidance: $43.6 million to $83.2 million. Organogenesis Holdings Inc (NASDAQ:ORGO) reported a 27% increase in net revenue for the fourth quarter, exceeding the high end of ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only ...

Organogenesis Holdings Inc (NASDAQ:ORGO) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $109.60 million, and the earnings are expected to ...